CRBU
CRBU
NASDAQ · Biotechnology

Caribou Biosciences Inc

$0.38
-0.01 (-2.69%)
Financial Highlights (FY 2026)
Revenue
12.94M
Net Income
-171,687,151
Gross Margin
—
Profit Margin
-1,327.4%
Rev Growth
-7.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.94M 13.90M 54.83M 47.58M
Gross Profit — — 18.34M 15.91M
Operating Income -182,572,126 -176,587,762 11.25M 10.65M
Net Income -171,687,151 -166,059,576 10.00M 7.87M
Gross Margin — — 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Rev Growth -7.0% -7.0% -2.4% +14.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 60.52M 50.56M
Total Equity — — 94.36M 88.94M
D/E Ratio — — 0.64 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -178,333,385 -182,070,624 16.80M 15.25M
Free Cash Flow — — 9.93M 9.62M